Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 USD | +5.99% | 0.00% | -18.06% |
Business Summary
Number of employees: 157
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Ophthalmic Retinal Pharmaceuticals
100.0
%
| 54 | 100.0 % | 81 | 100.0 % | +49.19% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
70.2
%
| 34 | 63.2 % | 57 | 70.2 % | +65.81% |
International
29.8
%
| 20 | 36.8 % | 24 | 29.8 % | +20.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Elliot Maltz
DFI | Director of Finance/CFO | 39 | Jan. 01 |
Jason Werner
COO | Chief Operating Officer | 46 | 23-05-16 |
David Dyer
PRN | Corporate Officer/Principal | - | 21-05-16 |
Philip Ashman
PRN | Corporate Officer/Principal | 59 | 12-12-31 |
General Counsel | - | 18-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
John Snisarenko
BRD | Director/Board Member | 61 | 19-07-17 |
Margaret Pax
BRD | Director/Board Member | 64 | Nov. 07 |
Michael Kaseta
BRD | Director/Board Member | 48 | 23-03-23 |
Adam Morgan
CHM | Chairman | 45 | 23-03-23 |
Jason Werner
COO | Chief Operating Officer | 46 | 23-05-16 |
Erin Parsons
BRD | Director/Board Member | 48 | 21-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 52,354,450 | 46,103,702 ( 88.06 %) | 0 | 88.06 % |
Company contact information
Alimera Sciences, Inc.
6310 Town Square Suite 400
30005, Alpharetta
+678 990 5740
http://www.alimerasciences.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.06% | 185M | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
-24.99% | 28.22B | |
+55.26% | 24.64B | |
-7.19% | 16.98B | |
-34.20% | 13.29B | |
-17.31% | 11.66B | |
-11.43% | 11.65B | |
-0.90% | 8.18B |
- Stock Market
- Equities
- ALIM Stock
- Company Alimera Sciences, Inc.